Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways

Samankaltaisia teoksia

• Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation
  Tekijä: Kang, Namju, et al.
  Julkaistu: (2019)
• Extracts of Flavoparmelia sp. Inhibit Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation
  Tekijä: Kim, Kwang-Jin, et al.
  Julkaistu: (2019)
• Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro
  Tekijä: Baek, Jong Min, et al.
  Julkaistu: (2017)
• Adrenomedullin inhibits osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand-induced nuclear factor-κB activation in glucocorticoid-induced osteoporosis
  Tekijä: Liu, Yuanxin, et al.
  Julkaistu: (2017)
• Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts
  Tekijä: Takegahara, Noriko, et al.
  Julkaistu: (2016)